{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T13:37:08Z","timestamp":1777901828791,"version":"3.51.4"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001118"],"award-info":[{"award-number":["82001118"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Psychiatry"],"abstract":"<jats:p>Acromegalic patients always demonstrate a wide range of clinic manifestations, including typical physical changes such as acral and facial features, as well as untypical neuropsychiatric and psychological disturbances. However, there is still a lack of clinical guidance on the treatment for acromegalic patients with psychiatric comorbidities. We therefore share this case to provide a reference for clinicians to manage the acromegalic patients with psychiatric symptoms. This case report describes a 41-year-old male with an 8-year history of acromegaly due to growth hormone-secreting pituitary adenoma, the maximum cross-sectional area of which was 42 mm \u00d7 37 mm demonstrated by pituitary magnetic resonance imaging (MRI). The patient received conservative medicine treatment by regularly injecting with Sandostatin LAR 10 mg per month. Two days before admission, he suddenly presented with an acute psychotic episode. In addition to the typical acromegaly-associated changes, his main clinical presentations were olfactory\/auditory hallucinations, reference\/persecutory delusions, instable emotion and impulsive behavior. Considering the schizophrenic-like psychoses and course features, he was diagnosed with Brief Psychotic Disorder according to Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) after a multidisciplinary consultation and evaluation. He was prescribed Aripiprazole, which had less extrapyramidal symptoms and minimal influence on prolactin elevation, with the dose of 5 mg per day to control the psychiatric symptoms and he responded quite well. At the time of discharge and the follow-up 2 month later, the patient was stable without recurrence of any psychotic symptoms. The levels of growth hormone (GH) and insulin-like growth factor 1 (IGF-1) 1 week after discharge were 2.22 ng\/mL [normal range (0\u20132.47 ng\/mL)] and 381 \u03bcg\/L [normal range (94\u2013284 \u03bcg\/L)], respectively, which were similar to those before the psychotic episode. Results from this report further supported that small dose of Aripiprazole had little influence on hormonal levels and the development of pituitary macroadenoma. This particular case emphasizes the importance for the clinician to master and carefully identify the possible symptoms of mental disorders associated with acromegaly, and also highlights the need for further investigation in more efficient treatment strategies for acromegalic cases with psychiatric comorbidities.<\/jats:p>","DOI":"10.3389\/fpsyt.2022.1068836","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T17:53:48Z","timestamp":1669917228000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case report: Treatment of psychiatric symptoms for an acromegalic patient with pituitary adenoma"],"prefix":"10.3389","volume":"13","author":[{"given":"Zhongyong","family":"Shi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enzhao","family":"Cong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinchun","family":"Mei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daihui","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11102-016-0772-8","article-title":"Acromegaly: clinical features at diagnosis.","volume":"20","author":"Vilar","year":"2017","journal-title":"Pituitary."},{"key":"B2","doi-asserted-by":"publisher","first-page":"3933","DOI":"10.1210\/jc.2014-2700","article-title":"Acromegaly: an endocrine society clinical practice guideline.","volume":"99","author":"Katznelson","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"key":"B3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1007\/s11102-016-0754-x","article-title":"Epidemiology of acromegaly: review of population studies.","volume":"20","author":"Lavrentaki","year":"2017","journal-title":"Pituitary"},{"key":"B4","doi-asserted-by":"publisher","first-page":"4081","DOI":"10.1210\/jc.2004-1381","article-title":"A nationwide survey of mortality in acromegaly.","volume":"90","author":"Kauppinen-Makelin","year":"2005","journal-title":"J Clin Endocrinol Metab."},{"key":"B5","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1210\/jc.2010-2490","article-title":"Coping strategies in patients after treatment for functioning or nonfunctioning pituitary adenomas.","volume":"96","author":"Tiemensma","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"key":"B6","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/j.1365-2265.2009.03555.x","article-title":"Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients.","volume":"71","author":"Sievers","year":"2009","journal-title":"Clin Endocrinol."},{"key":"B7","first-page":"297","article-title":"Sur deux cas d\u2019acromegaly; hypertrophie singuliere non congenital le des extremities superierures, inferieures et cephalique.","volume":"6","author":"Marie","year":"1986","journal-title":"Rev M\u00e9d Li\u00e8ge."},{"key":"B8","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/j.1365-2265.2009.03626.x","article-title":"Features at diagnosis of 324 patients with acromegaly did not change from 1981 to 2006: acromegaly remains under-recognized and under-diagnosed.","volume":"72","author":"Reid","year":"2010","journal-title":"Clin Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1007\/s10143-019-01134-z","article-title":"Pituitary adenomas and neuropsychological status: a systematic literature review.","volume":"43","author":"Pertichetti","year":"2020","journal-title":"Neurosurg Rev."},{"key":"B10","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1007\/s11102-011-0326-z","article-title":"Cognitive function in acromegaly: description and brain volumetric correlates.","volume":"15","author":"Sievers","year":"2012","journal-title":"Pituitary."},{"key":"B11","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1210\/jc.2010-0394","article-title":"Evidence of cognitive and neurophysiological impairment in patients with untreated naive acromegaly.","volume":"95","author":"Leon-Carrion","year":"2010","journal-title":"J Clin Endocrinol Metab."},{"key":"B12","doi-asserted-by":"publisher","first-page":"524","DOI":"10.5603\/EP.a2017.0044","article-title":"Is there any difference in acromegaly and other chronic disease in quality of life and psychiatric morbidity?","volume":"68","author":"Szcze\u015bniak","year":"2017","journal-title":"Endokrynol Pol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"18","DOI":"10.17116\/jnevro20161169118-23","article-title":"[Mental disorders in patients with acromegaly].","volume":"116","author":"Bobrov","year":"2016","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova."},{"key":"B14","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1600-0447.1987.tb02848.x","article-title":"Psychiatric morbidity in acromegaly.","volume":"75","author":"Abed","year":"1987","journal-title":"Acta Psychiatr Scand."},{"key":"B15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s11102-008-0143-1","article-title":"Macroscopic brain architecture changes and white matter pathology in acromegaly: a clinicoradiological study.","volume":"12","author":"Sievers","year":"2009","journal-title":"Pituitary."},{"key":"B16","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s11102-012-0447-z","article-title":"Diagnostic delay is associated with psychosocial impairment in acromegaly.","volume":"16","author":"Siegel","year":"2013","journal-title":"Pituitary."},{"key":"B17","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly.","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Primers."},{"key":"B18","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3390\/biomedicines9050494","article-title":"Pituitary adenomas: from diagnosis to therapeutics.","volume":"9","author":"Banskota","year":"2021","journal-title":"Biomedicines."},{"key":"B19","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1177\/2045125311433581","article-title":"Risperidone-induced acromegaly: a case report.","volume":"2","author":"Koroglu","year":"2012","journal-title":"Ther Adv Psychopharmacol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1093\/schbul\/sbu028","article-title":"Curious cases: acromegaly and schizophrenia: an incidental association?","volume":"40","author":"Iglesias","year":"2014","journal-title":"Schizophr Bull."},{"key":"B21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1056\/NEJM197104152841504","article-title":"Acromegaly treated with chlorpromazine. A case study.","volume":"284","author":"Kolodny","year":"1971","journal-title":"N Engl J Med."},{"key":"B22","doi-asserted-by":"publisher","first-page":"S108","DOI":"10.1016\/j.euroneuro.2008.02.004","article-title":"Prolactin awareness: an essential consideration for physical health in schizophrenia.","volume":"18","author":"Montejo","year":"2008","journal-title":"Eur Neuropsychopharmacol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/YIC.0000000000000247","article-title":"Antipsychotics and pituitary tumors: an analysis of the European pharmacovigilance database (EudraVigilance).","volume":"34","author":"Lertxundi","year":"2019","journal-title":"Int Clin Psychopharmacol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1592\/phco.26.6.748","article-title":"Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.","volume":"26","author":"Szarfman","year":"2006","journal-title":"Pharmacotherapy."},{"key":"B25","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1080\/10401230490487007","article-title":"Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders.","volume":"16","author":"Gupta","year":"2004","journal-title":"Ann Clin Psychiatry."}],"container-title":["Frontiers in Psychiatry"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1068836\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T17:53:50Z","timestamp":1669917230000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpsyt.2022.1068836\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":25,"alternative-id":["10.3389\/fpsyt.2022.1068836"],"URL":"https:\/\/doi.org\/10.3389\/fpsyt.2022.1068836","relation":{},"ISSN":["1664-0640"],"issn-type":[{"value":"1664-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"1068836"}}